Table 2.
Time [days]◆: | 0 | 28 | 35 | |
---|---|---|---|---|
Treatment group | Animal | |||
Vaccinated | V1 | 0.057* | 0.185 | 0.736 |
V2 | 0.056 | 0.267 | 0.476 | |
V3 | 0.054 | 0.223 | ||
V4 | 0.051 | 0.121 | 0.542 | |
V5 | 0.052 | 0.054 | 0.408 | |
Average# | 0.054a | 0.157a | 0.477a | |
Unvaccinated | C1 | 0.055 | 0.059 | 0.099 |
C2 | 0.052 | 0.060 | 0.214 | |
C3 | 0.056 | 0.055 | 0.106 | |
C4 | 0.057 | 0.060 | 0.067 | |
Average | 0.055a | 0.059a | 0.121b |
◆ Calves were infected intranasally with live BRSV 28 days after vaccination with one dose of the inactivated BRSV-PI3-Mh combination vaccine.
*According to the information of the manufacturer of the assay, values above the cut-off level (0.207) have to be interpreted as positive - indicated by the bold letter type
# Average values with different superscript letters are significantly different (p < 0.05) from each other.